These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16884069)

  • 21. [Compliance of medical treatment in primitive glaucoma open angle].
    Wane AM; Ndiaye MR; Wade A; Ndiaye PA; Ba EA; de Medeiros ME; Ndoye PA; Ndiaye CS; Kameni A
    J Fr Ophtalmol; 2003 Dec; 26(10):1039-44. PubMed ID: 14691397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting compliance with eye drop therapy for glaucoma in a multicultural outpatient setting.
    Curtis C; Lo E; Ooi L; Bennett L; Long J
    Contemp Nurse; 2009 Feb; 31(2):121-8. PubMed ID: 19379114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alterations of intraocular pressure in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular pressure measurements].
    Böhm MR; Lill TM; Eter N; Prokosch-Willing V
    Klin Monbl Augenheilkd; 2014 Aug; 231(8):810-7. PubMed ID: 25133559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe].
    Levrat F; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 1999 Mar; 22(2):186-91. PubMed ID: 10327349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of the Travalert(®) dosing aid on medical treatment compliance and the quality of life of glaucoma patients].
    Sánchez-Pulgarín M; Martínez-de-la-Casa JM; Escalada A; Sáenz-Francés F; García-Feijoó J; García Sánchez J
    Arch Soc Esp Oftalmol; 2011 Sep; 86(9):282-6. PubMed ID: 21893261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of patient compliance in the management of glaucoma].
    Popović Suić S; Cerovski B; Jukić T
    Acta Med Croatica; 2008 Feb; 62(1):57-9. PubMed ID: 18365501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India.
    Rajurkar K; Dubey S; Gupta PP; John D; Chauhan L
    J Curr Ophthalmol; 2018 Jun; 30(2):125-129. PubMed ID: 29988888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes of physicians, patients, and village health workers toward glaucoma and diabetic retinopathy in rural China: a focus group study.
    Yan X; Liu T; Gruber L; He M; Congdon N
    Arch Ophthalmol; 2012 Jun; 130(6):761-70. PubMed ID: 22801838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment.
    Stewart WC; Konstas AG; Pfeiffer N
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):461-9. PubMed ID: 15684806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Compliance of treatment in glaucoma patients].
    Banc A; Stan C
    Oftalmologia; 2013; 57(2):51-9. PubMed ID: 24386793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving eye drop treatment for glaucoma through better adherence.
    Quigley HA
    Optom Vis Sci; 2008 Jun; 85(6):374-5. PubMed ID: 18521018
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
    Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
    J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Causes of patients' non-adherence with glaucoma medication dosing: systemic classification based on dosing schedule].
    Kobayashi H
    Nippon Ganka Gakkai Zasshi; 2011 Dec; 115(12):1086-93. PubMed ID: 22312813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving compliance with glaucoma eye-drop treatment.
    Cooper J
    Nurs Times; 1996 Aug 7-13; 92(32):36-7. PubMed ID: 8826416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glaucoma diagnostics.
    Geimer SA
    Acta Ophthalmol; 2013 Feb; 91 Thesis 1():1-32. PubMed ID: 23384049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glaucoma patients treated by practicing ophthalmologists in Denmark. Estimated number of patients and the extent of visual field defects].
    Lundberg LU; Thygesen J; Damgaard-Jensen L; Serup L; Kessing SV
    Ugeskr Laeger; 2000 May; 162(21):3028-33. PubMed ID: 10850191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of long-term administration of timolol eye drops in open-angle glaucoma (author's transl)].
    Demmler N; Müller-Bardorff G
    Klin Monbl Augenheilkd; 1980 Jul; 177(1):91-3. PubMed ID: 6779049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eye drop instillation technique among patients with glaucoma and evaluation of pharmacists' roles in improving their technique: an exploratory study.
    Kan YM; Kho BP; Kong L; Chong QX; Tiong MNJ; Wong LMJ
    Int J Pharm Pract; 2022 Dec; 30(6):520-525. PubMed ID: 35942810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.